Search results
... AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) AND PSEUDOMONAS AERUGINOSA (PA) IN...
The Fairfax County Times· 18 hours agoOmeza®, a regenerative skincare company that develops marine-based therapies for the treatment of chronic wounds, recently presented in vivo data showing that OCM™ wound matrix alone significantly ...
FY2024 Earnings Forecast for Spero Therapeutics, Inc. (NASDAQ:SPRO) Issued By Cantor Fitzgerald
ETF DAILY NEWS· 6 hours agoSpero Therapeutics, Inc. (NASDAQ:SPRO – Free Report) – Equities research analysts at Cantor Fitzgerald decreased their FY2024 earnings estimates for Spero Therapeutics in a research note issued ...
WHO updates list of drug-resistant bacteria most threatening to human health
World Health Organization· 4 days agoThe World Health Organization (WHO) today released its updated Bacterial Priority Pathogens List...
After seven years, WHO updates antibiotic-resistant bacteria list
Investing.com· 4 days agoAfter seven years, WHO updates antibiotic-resistant bacteria list
WHO updates bacterial priority pathogens list
Center for Infectious Disease Research and Policy· 4 days agoThe World Health Organization (WHO) today updated its list of the bacterial pathogens it considers the biggest threat to human health. The updates are...
I'm a U.S. surgeon in Gaza—there was no bleach to treat a woman's wounds
Newsweek· 21 hours agoTwo months ago, I was in Gaza volunteering in a healthcare system that is progressively collapsing....
Lipase-mediated detoxification of host-derived antimicrobial fatty acids by Staphylococcus aureus -...
Nature· 6 days agoThis study on how Staphylococcus aureus manipulates host-derived fatty acids reveals that a bacteriallipase (Lip2) converts toxic fatty acids and cholesterol into innocuous cholesteryl esters.
Things You Should Know Before Your Next Trip To McDonald's
Mashed via Yahoo News· 6 days agoWhen swabbed, 42% of the sampled fountain drink dispensers came back positive for coliform bacteria....
Machine learning model uncovers new drug design opportunities
Phys.org· 7 days agoPathogens are nothing if not adaptable, and their ability to protect themselves against antibiotics increasingly poses a public health concern. A research team led by Los Alamos National Laboratory ...
EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of...
The Herald Journal· 6 days agoMajor Milestone for EVŌQ Nano's Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung Diseases